Rafferty Asset Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1389426
New York, NY
Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,726,471
-$1,180,106 QoQ
Shares Held
50,553
+12.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $409,131,400 across 136 Biotechnology names. ALNY ranks #4 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,726,471 | 50,553 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,906,577 | 45,031 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,820,856 | 17,151 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,498,793 | 32,196 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,038,841 | 44,585 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,428,368 | 52,817 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,555,439 | 63,831 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $19,709,730 | 81,110 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,147,236 | 61,206 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,107,979 | 52,808 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,822,152 | 44,168 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,272,456 | 43,553 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,650,421 | 38,191 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,627,407 | 36,303 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,583,662 | 32,892 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,549,061 | 31,190 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,047,445 | 37,035 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,417,233 | 31,945 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,102,148 | 16,430 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,679,941 | 15,809 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,307,799 | 23,428 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $934,354 | 7,189 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,359,593 | 16,206 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,472,657 | 9,943 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $444,108 | 4,080 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||